Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy

International Journal of Diabetes in Developing Countries

Volumn 28, Issue 1, 2008, Pages 26-30

  Hettihewa, L ^a,b   Jayasinghe, S ^a   Imendra, K ^a   Weerarathna, T ^b  

^a UNIVERSITY OF RUHUNA   (Sri Lanka)

^b UNIVERSITY OF RUHUNA   (Sri Lanka)

Author keywords

Blood pressure; Insulin resistance; Pioglitazone; Type 2 diabetes mellitus

Indexed keywords

EID: 48849093510     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.41983     Document Type: Article

References (25)

1. Simonaon DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 1998;11:821-7.
2. Rosenstock J, Raskin P. Hypertension in diabetes mellitus. Cardiol Clin 1988;6:547-60.
3. Morales PA, Mitchell BD, Valdez RA, Hazerda HP. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects: The San Antonio Heart Study. Diabetes 1993;42:154-61.
4. Mogensen CE, Christensen CK. Predicting diabetes nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
5. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: An update. Hypertension 1995;26:869-79.
6. Gall MA, Borch-Johnsen K, Houggard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995;44:1303-9.
7. Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle age diabetic men: A general population study. BMJ 1989;299:1127-31.
8. Ferrannini E, Haffner SM, Stern MP. Essential hypertension: An insulin-resistant state. J Cardiovase Pharmacol 1990;15:S18-25.
9. Bonner G. Hyperinsulinemia, insulin resistance and hypertension. J Cardiovasc Pharmacol 1994;24:S39-49.
10. Morris AD, Conne JM. Insulin resistance and essential hypertension: Mechanisms and clinical implications. Am J Med Sci 1994;307:S47-52.
11. Weidmann P, de Courten M, Bohlen L. Insulin resistance, hyperinsulinemia and hypertension. J Hypertens 1993;11:S27-38.
12. Goutham R. Insulin resistance syndrome. Am Fam Physician 2001;63:1159-63.
13. Ogihara T, Raguki H, Ikegumi H, Mikami H, Masuo K. Enhancement of insulin sensitivity to troglitazone lowers blood pressure in diabetic hypertensive. Am J Hypetens 1995;8:316-20.
14. Nolan JJ, Ludwik B, Beerdsen P, Joyce M. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331:1188-93.
15. ++2 current and not endothelial nitric oxide production. Diabetes 1997;46:659-64.
16. Fujishima S, Ohhya Y, Nakamura Y, Onaka U, Abe I. Troglitazone an insulin sensitizer increases forearm blood flow in humans. Am J Hypertens 1998;11:1134-7.
17. McAuley KA, Williams SM, Mann JI, Walker RJ, Ledwis-Barned NJ. Diagnosing insulin resistance in general population. Diabetes Care 2001;24:460-4.
18. Matthews DR, Hosker P, Rudenski AS, Naylor B, Teacher D. Homeostasis model assessment: Insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
19. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA. Quantitative insulin sensitivity check index: A simple accurate method of assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
20. Bong HS, Joseph LI, Izzo J, Paresh D, Mchael F. Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus. Hypertension 1999;83-8.
21. Raj A, Gordon HW, Ellen W, Shannon A, Donald C. Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients. Diabetes Care 2003;26:172-8.
22. Juhan VI, Alessi M, Pai I. Obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997;78:656-60.
23. Reaven G, Banting. Lecture role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
24. Hughes K, Aw T, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, Lipoprotein and cardiovascular risk in Indians: Malays and Chinesein Singapore. J Epidemiol Community Health 1997;51:394-9.
25. Mundal R, Kjedsen SE, Sandwik L, Erickssen G, Thaulow E. Exercise blood pressure predicts cardioavascular mortality in middle-aged men. Hypertension 1994;24:56-62.